Pasar al contenido principal

CARACTERIZACION MOLECULAR, PREVENCION Y TERAPIA DE LINAJES HIPERVIRULENTOS CAUSANTES DE ENFERMEDAD NEUMOCOCICA

PID2024-161570OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE SALUD CARLOS III DE MADRID (ISCIII)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, Spain

  • Llorente, Joaquín
  • Sempere, Julio
  • Llamosí, Mirella
  • Pérez-García, Covadonga
  • Úbeda, Aída
  • Vidal-Alcántara, Erick Joan
  • Sanz, Juan Carlos
  • Domenech, Mirian
  • Yuste, José
Pneumococcal conjugate vaccines (PCVs) have significantly reduced disease burden caused by Streptococcus pneumoniae, a leading cause of childhood morbidity and mortality globally. The rise of non-vaccine serotypes is a frequent phenomenon after the use of these PCVs. This study is a national surveillance that includes all pneumococcal isolates causing invasive pneumococcal disease (IPD) (4,455 isolates) in the pediatric population to analyze the changes of strains with reduced susceptibility (IPD-RS) to different antibiotics (1,458 to penicillin/1,304 to erythromycin) and the impact of PCVs and COVID-19 pandemic on antibiotic resistance. Six periods are differentiated according to this decline: pre-PCV13, early PCV13, middle PCV13, late PCV13, COVID-19, and reopening. Between 2009 and 2023, overall IPD cases in Spain decreased by over 60% in children aged 1–4 years and by approximately 50% in infants under 1 year of age. Nevertheless, an increase in IPD-RS caused by non-PCV13 serotypes was observed, with serotype 24F being the most prevalent, which is not included in the currently licensed PCVs. The introduction of PCV13 showed a substantial impact on reducing IPD in children. The COVID-19 pandemic led to a temporary decline in the burden of disease caused by resistant strains in 2020 due to non-pharmacological measures followed by a subsequent recovery., This study was supported by the Spanish Ministry of Science and Innovation (grant PID2024-161570OB-I00) and by the Instituto de Salud Carlos III (grant PI24CIII/00045). This study was also partially funded by grants from Merck Sharp Dohme (grant MISP#IISP60170) although this funder had no intervention in the results of this study. J.Y. and M.D. conceptualized and designed the study, drafted the initial manuscript, and reviewed and revised the manuscript for important intellectual content. J.L. and J.S. contributed to the study conception, drafted the initial manuscript, data analysis, and interpretation. M.L., C.P.-G., A.Ú., and E.J.V.-A. provided technical support for the study. J.C.S. critically reviewed the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Upsurge of pneumococcal clade I-α/CC180 serotype 3 and its association with a LytA mutation linked to immune evasion and disease potential: an observational and experimental study

  • Pérez-García, Covadonga
  • Sempere, Julio
  • Llamosí, Mirella
  • González-Díaz, Aída
  • de Miguel, Sara
  • Vidal-Alcántara, Erick Joan
  • Sanz, Juan Carlos
  • García, Ernesto
  • Brueggemann, Angela B
  • Ardanuy, Carmen
  • Domenech, Mirian
  • Yuste, Jose
Background Streptococcus pneumoniae serotype 3 is one of the most prevalent serotypes that cause invasive pneumococcal disease (IPD) in children and adults worldwide. Serotype 3 is associated with vaccine failures and breakthrough episodes in children vaccinated with 13-valent pneumococcal conjugate vaccine (PCV13). In this study, we aimed to investigate potential genetic mechanisms that could explain the increase in cases of serotype 3 IPD in Spain. Methods We analysed the epidemiology of serotype 3 causing IPD in Spain, during 2009–23, in different age groups. Molecular characterisation was performed by whole-genome sequencing. Host–pathogen interactions of the different lineages were evaluated in terms of interaction with lung epithelial cells, biofilm formation, and capsular polysaccharide production, using opsonophagocytosis assays and mouse models of pneumonia. We used Poisson regression models to compare incidence and chi-square test calculations to identify clonal variations across vaccine periods. Findings Genomic analyses confirmed the predominance of clade I-α/clonal complex (CC) 180 in Spain, which shows increased resistance to complement-mediated immunity and phagocytosis and enhanced potential to infect lung cells. In all isolates of this lineage, we observed a single amino acid substitution (166His→Tyr) in the crucial virulence factor LytA, which increased its enzymatic activity. On evaluating the phagocytosis of mutants without LytA of the two major lineages of serotype 3 (CC180 and CC260), LytA was responsible for the increased phagocytosis-evasion pattern of clade I-α/CC180. Evaluation of individuals with IPD caused by different serotype 3 genotypes confirmed a significant (p < 0·05) association between cardiac and respiratory comorbidities and infection by sequence type 180/CC180, which showed the importance of CC180 in IPD. Interpretation Our findings confirm that PCV13 reduced IPD cases caused by the susceptible CC260 lineage until CC260 was replaced by the clade I-α/CC180 lineage, which has a higher potential to cause IPD and divert the host immune system. A key mutation on LytA protein was associated with this hypervirulent phenotype. Emerging lineages jeopardise the effectiveness of pneumococcal conjugate vaccines, This work was supported by Ministerio de Ciencia e Innovación (MICINN; PID2020-119298RB-I00 and PID2024-161570OB-I00) and an internal fund from Instituto de Salud Carlos III (ISCIII). CP-G was supported by a Formación del Profesorado Universitario fellowship from MICINN (FPU21/01798). This study was also funded in part by grants from MSD (MISP#IISP60170), although this funder had no intervention in the results of this study. PubMLST is supported by a Wellcome Trust Biomedical Resource Grant (218205/Z/19/Z), Peer reviewed, Modelo experimental alternativo-NAM, Organismos alternativos no vertebrados - Microorganismos Unicelulares - Bacterias